David Charles Lubner

Insider Reports History

Location
Watertown, MA
Signature
/s/ Michelle Gilson, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Charles Lubner:

Company Role Class Num Shares Value Price $ Report Date Ownership
Arcellx, Inc. Director Common Stock 21,659 $1,624,425 $75.00 20 Jan 2026 Direct
Arcellx, Inc. Director Stock Option (right to buy) 59,405 20 Jan 2026 Direct
Dyne Therapeutics, Inc. Director Stock option (right to buy) 35,000 30 May 2025 Direct
Vor Biopharma Inc. Director Stock Option (Right to Buy) 30,000 22 May 2025 Direct
GLYCOMIMETICS INC Director Stock Option (Right to Buy) 9,023 23 Jun 2025 Direct
CARGO Therapeutics, Inc. Director Stock Option (Right to Buy) 0 19 Aug 2025 Direct
Gemini Therapeutics, Inc. /DE Director Stock Option (Right to Buy) 0 04 Oct 2021 Direct
POINT Biopharma Global Inc. Director Common Stock 0 $12.45 27 Dec 2023 Direct
POINT Biopharma Global Inc. Director Stock Option (Right to Buy) 0 27 Dec 2023 Direct

Insider Reports Filed by David Charles Lubner

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACLX Arcellx, Inc. 20 Jan 2026 3 -$412,320 4 Director 20 Jan 2026, 19:59
CRGX CARGO Therapeutics, Inc. 19 Aug 2025 1 $0 4 Director 19 Aug 2025, 16:43
GLYC GLYCOMIMETICS INC 23 Jun 2025 1 $0 4 Director 23 Jun 2025, 18:41
CRGX CARGO Therapeutics, Inc. 18 Jun 2025 1 $0 4 Director 20 Jun 2025, 17:40
GLYC GLYCOMIMETICS INC 13 Jun 2025 0 $0 3 Director 23 Jun 2025, 18:24
DYN Dyne Therapeutics, Inc. 30 May 2025 1 $0 4 Director 03 Jun 2025, 21:40
ACLX Arcellx, Inc. 29 May 2025 1 $0 4 Director 30 May 2025, 16:11
VOR Vor Biopharma Inc. 22 May 2025 1 $0 4 Director 23 May 2025, 17:45
CRGX CARGO Therapeutics, Inc. 04 Jun 2024 1 $0 4 Director 06 Jun 2024, 16:29
ACLX Arcellx, Inc. 28 May 2024 1 $0 4 Director 06 Jun 2024, 16:15
VOR Vor Biopharma Inc. 23 May 2024 1 $0 4 Director 28 May 2024, 16:10
DYN Dyne Therapeutics, Inc. 22 May 2024 1 $0 4 Director 24 May 2024, 17:10
/report/000110465923129769-lubner-david-charles-2023-12-26 POINT Biopharma Global Inc. 26 Dec 2023 5 $0 4 Director 27 Dec 2023, 17:37
CRGX CARGO Therapeutics, Inc. 09 Nov 2023 1 $0 4 Director 13 Nov 2023, 18:49
CRGX CARGO Therapeutics, Inc. 09 Nov 2023 0 $0 3 Director 09 Nov 2023, 17:07
ACLX Arcellx, Inc. 14 Jun 2023 1 $0 4 Director 16 Jun 2023, 16:17
/report/000110465923068141-lubner-david-charles-2023-06-01 POINT Biopharma Global Inc. 01 Jun 2023 1 $0 4 Director 05 Jun 2023, 17:35
VOR Vor Biopharma Inc. 26 May 2023 1 $0 4 Director 02 Jun 2023, 16:36
DYN Dyne Therapeutics, Inc. 24 May 2023 1 $0 4 Director 25 May 2023, 18:37
/report/000110465922122395-lubner-david-charles-2022-11-23 POINT Biopharma Global Inc. 23 Nov 2022 1 +$24,660 4 Director 28 Nov 2022, 15:03
DYN Dyne Therapeutics, Inc. 05 Jul 2022 1 $0 4 Director 06 Jul 2022, 18:21
VOR Vor Biopharma Inc. 14 Jun 2022 1 $0 4 Director 16 Jun 2022, 17:05
DYN Dyne Therapeutics, Inc. 03 Jun 2022 1 $0 4 Director 06 Jun 2022, 16:07
/report/000110465922068509-lubner-david-charles-2022-06-02 POINT Biopharma Global Inc. 02 Jun 2022 1 $0 4 Director 06 Jun 2022, 16:04
ACLX Arcellx, Inc. 08 Feb 2022 2 $0 4 Director 09 Feb 2022, 16:52
ACLX Arcellx, Inc. 03 Feb 2022 1 $0 4 Director 07 Feb 2022, 17:00
ACLX Arcellx, Inc. 03 Feb 2022 0 $0 3 Director 03 Feb 2022, 16:29
IRON Gemini Therapeutics, Inc. /DE 04 Oct 2021 1 $0 4/A Director 09 Mar 2022, 17:13
/report/000110465921090262-lubner-david-charles-2021-07-06 POINT Biopharma Global Inc. 06 Jul 2021 1 $0 4 Director 08 Jul 2021, 16:38
DYN Dyne Therapeutics, Inc. 26 May 2021 1 $0 4 Director 27 May 2021, 20:37
IRON Gemini Therapeutics, Inc. /DE 12 Mar 2021 1 $0 4/A Director 09 Mar 2022, 17:15